Cite

HARVARD Citation

    Zhovtis Ryerson, L. et al. (2016). Extended interval dosing of natalizumab in multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 87 (8), pp. 885-889. [Online]. 
  
Back to record